Proactive Investors - Finance
09 Jul 2026, 07:19 UTC · 2h ago
FTSE 100 Live: Stocks called higher as Trump signals Iran ready for talks
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Proactive Investors - Finance
09 Jul 2026, 07:19 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
AstraZeneca's Phase III CARDIO-TTRansform trial of the drug Wainua failed to meet its primary endpoint in treating a rare heart disease. — The failure of a major late-stage pipeline opportunity removes a significant growth driver and caused a 9% share price plunge.
-0.80Investors are reacting to the Wainua trial failure with concerns over AstraZeneca management's credibility regarding trial design and confidence. — Loss of confidence in management often leads to a valuation discount beyond the immediate financial loss of a failed drug.
-0.50Computacenter shares rose over 13% following a positive trading update. — Direct positive reaction to improved operational performance and financial outlook.
+0.40Continue reading
6 related stories
Top 3 movers · tap to explore
Seraphim Space Investment Trust sold its portfolio company ALL.SPACE for a total value lower than its last reported carrying value. — The sale represents a realized loss relative to the asset's previous fair value assessment.
-0.20The National Energy System Operator issued an electricity margin notice due to tight margins caused by extreme European temperatures. — While routine, it signals system stress and potential volatility in energy availability/pricing.
-0.10Which stocks this story touches
Market value dropped £20 billion following the failure of the Phase III CARDIO-TTRansform trial.
Share price jumped over 13% following a positive trading update.
Company has cut its financial guidance due to operational problems.
Stock price is up 3% or more.
Stock price is up 3% or more.
Stock price is up 3% or more.
Sale of portfolio company occurred at a value below its last reported carrying value.
Mentioned only in the context of relative market capitalization.
Mentioned only in the context of relative market capitalization.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
CNBC
2h ago
